Menu

Investment

HomeAll PostsInvestment

CBD Therapeutics Startup Prima Raises a $9.2M Seed Plus Round

Investment, News, Uncategorized May 24, 2021
Share

Prima, a purpose-driven brand focused on efficacy-driven and science-backed plant therapeutics and cannabinoids, today announced the close of a $9.2M Seed Plus financing led by leading institutional venture firms Greycroft, H Ventures, Defy, and Lerer Hippeau, with participation from Adam Zeplain (mark vc), Global Founders Capital, Emerald Health, One Gun, and Purple Arch Ventures.  The funding will support sustainable growth and power upcoming retail expansion, remedy-focused clinical research, portfolio refinements and education initiatives…

Prenatal Genetic Testing Company JunoDx Raises a $25M Series A

Investment, News, Reproductive Health May 18, 2021
Share

JunoDx, a company focused on improving access to vital genetic health information, announced today the closing of an expanded Series A financing round of $25M led by the Perceptive Xontogeny Venture (PXV) Fund. The capital will be used to support clinical validation studies, product development, and commercial launch of JunoDx’s product offerings for noninvasive prenatal testing (NIPT). “We are excited to partner…

Sexual Wellness Company Vella Bioscience raises a $7M Seed II Round for Further Product Development and Expansion

Investment, News, Sexual Wellness May 14, 2021
Share

Only 2 weeks after its official launch, Vella Bioscience the company behind Vella Women’s Pleasure Serum, a clinically demonstrated pre-play topical serum that promotes increased arousal and lubrication, and more frequent, intense, and satisfying orgasms, has closed a $7 million seed II funding round, anchored by Aaron Fleck & Associates. The oversubscribed funding round puts Vella Bioscience at over $50 million post-money valuation, positioning the company to move forward on…

Alife Health raises a $9M Seed Round to Improve IVF Outcomes

Fertility, Investment, News, Reproductive Health May 7, 2021
Share

1 in 8 families now struggle with infertility. Studies show that the average healthy couple has a 20 percent natural fertility rate per cycle, and miscarriages in women are increasing by about 1 percent each year. Additionally, Black and Latinx women are less likely to access fertility care and have a successful IVF pregnancy. As fertility continues to be in crisis, new artificial…

Femtech Startup Kasha Receives Investment from Mastercard to Further Scale Its Platform and Support Micro-Entrepreneurs in Africa

Access, Investment, News, Women's Health May 5, 2021
Share

Mastercard today expanded its relationship with Kasha through an investment in the purpose driven ecommerce platform. Combining online and offline capabilities, Kasha’s platform allows women across rural and urban locations to make confidential personal care orders. By utilizing the full product catalogue available online, or by placing orders using basic mobile handsets, women can search, order and pay for hygiene products that…

Bone Health Technologies Raises $2.5M for OsteoBoost, its Vibration Belt for the Prevention of Osteoporosis

Bone Health, Investment, News, Uncategorized May 4, 2021
Share

Bone Health Technologies, an innovator of technologies for improving bone health, announces today the close of its $2.5 million funding round and the appointment of three board members: Karen Drexler, MBA, Nancy Lynch, MD, MBA and Sam Goldberger, MD, MBA. “Our mission is to provide an effective and safe treatment for the more than 40 million Americans with low bone density – this capital and the expertise…

Femtech Investment Round-up (April 2021)

Inner Circle, Investment, Investment Round-ups May 1, 2021
Share

At the beginning of each month, we look back and share which companies have announced new funding rounds. Below is April 2021’s round-up. You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet…

Pregnancy Company Sera Prognostics Completes a $100 Million Series E Financing to Expand Commercialization of its PreTRM Test

Biotech, Investment, News, Pregnancy April 29, 2021
Share

Sera Prognostics, “The Pregnancy Company”, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the completion of a $100 million Series E financing. Several leading healthcare-focused institutional investors have joined this financing round, including Vivo Capital, aMoon Fund, Parian Global, and others, led by existing investors Anthem, Inc., and Blue Ox Healthcare…